Latest Pap test Stories
Task Force says annual screening for asymptomatic women is unnecessary OTTAWA, Jan. 7, 2013 /CNW/ - The Canadian Task Force on Preventive Health Care (Task Force) today released an updated guideline on cervical cancer screening, recommending women aged 25-69 be screened at an interval of three years. The Task Force, an independent body of fourteen specialists with expertise in prevention, and primary care in Canada, says early and frequent (often annual) cervical screening is...
Lawrence LeBlond for redOrbit.com - Your Universe Online All too often women are being screened for cervical cancer when they do not need it, say researchers. Many women are having the cancer screening even after they have had a full hysterectomy. Recent data from the US Centers for Disease Control and Prevention (CDC) shows that about 60 percent of women who no longer have a cervix still get cervical cancer screening. For years, experts have said that women who have had a full...
Ikonisys, a leader in cell-based diagnostic solutions including their signature oncoFISH® cervical test, hires veteran business strategist and financial executive James A. Bento as their new chief executive officer. Bento is charged with taking the company to national prominence, leveraging their leadership in FISH-based laboratory testing in the Northeast. New Haven, CT (PRWEB) December 12, 2012 Ikonisys, a leader in cell-based diagnostic solutions including its signature...
MPLN converting HPV Testing to Hologic/Gen-Probe APTIMA ASSAY. Maryville, TN (PRWEB) December 06, 2012 MPLN announced today that they will be adopting the Hologic/Gen-Probe APTIMA Human papillomavirus (HPV) assay effective January 2, 2013. This assay will be run on the fully automated high throughput TIGRIS DTS System. “Our goal at MPLN is to offer our clients the most comprehensive experience in molecular diagnostics, and we believe the new Hologic/Gen-Probe APTIMA HPV assay is a...
SAN DIEGO, Calif., Nov. 27, 2012 /PRNewswire/ -- Trovagene, Inc. (NASDAQ: TROV) and the PIO XII Foundation, affiliated with Brazil's Barretos Cancer Hospital, today announced that they entered into a research collaboration to evaluate the performance of a urine-based molecular assay for detection of HPV types associated with cervical lesions. The goal of the study is to determine whether this assay can potentially replace Pap smears as the primary screen for cervical cancer risk in...
But treated women still at greater risk of cervical cancer than women not needing treatment Testing women to see if they are cured of HPV (the virus that can cause genital warts and cervical cancer) following treatment for abnormal cells on the surface of the cervix is more effective and cheaper than cytology testing (cervical screening) alone, suggests a study published on bmj.com today. A second study published today, finds that the risk of cervical cancer after treatment and cytological...
ALBANY, New York, October 26, 2012 /PRNewswire/ -- According to a new market report published by Transparency Market Research (http://www.transparencymarketresearch.com), "Cervical Cancer Diagnostic Tests (Pap Smear, Colposcopy and ECC Procedures) Market - Global Industry Analysis by Test Type and Age Group, Market Size, Share and Forecast, 2012 - 2018 [http://www.transparencymarketresearch.com/cervical-cancer-diagnostic-tests-market.html ]," the global Pap smear test market...
NORTHFIELD, Ill., Oct. 19, 2012 /PRNewswire/ -- The lives of 166 local women were changed this month during See, Test & Treat® , a 3-day cancer screening program supported with grants from the College of American Pathologists (CAP) Foundation and the CAP. The program, held at the NorthPoint Health & Wellness Clinic in Minneapolis, Minn., offered free cervical and breast cancer screening tests to underserved and uninsured women, along with same-day diagnoses and follow-up...
Screening for cervical cancer was low among women who self-identified as lesbian — a finding that places them at a potentially elevated risk for the disease, according to data presented at the 11th Annual AACR International Conference on Frontiers in Cancer Prevention Research, held here Oct. 16-19, 2012. "Despite our knowledge of the value of Pap testing for early detection of treatable cervical abnormalities, lesbians are one subset of women who are not getting screened at recommended...
BEDFORD, Mass., Oct. 16, 2012 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's APTIMA HPV 16 18/45 Genotype Assay for use on its TIGRIS instrument system. Hologic's APTIMA HPV 16 18/45 Genotype Assay is...
Latest Pap test Reference Libraries
The Colposcopy is a preventive procedure to identify a possible abnormal cells or tissue on the cervix, vagina and vulva. By illuminating and magnifying the area with a coloscope during the examination, areas of concern can be identified earlier by the colposcopist. The procedure was developed by a German physician Hans Hinselmann in 1925 with the help of Dr. Helmut Wirths. Cause for the Procedure This examination has multiple candidates. If a patient has been a victim of a sexual...
The Colposcopy is a preventive procedure to identify a possible abnormal cells or tissue on the cervix, vagina and vulva. By illuminating and magnifying the area with a coloscope during the examination, areas of concern can be identified earlier by the colposcopist. The procedure was developed by a German physician Hans Hinselmann in 1925 with the help of Dr. Helmut Wirths. Cause for the Procedure This examination has multiple candidates. If a patient has been a victim of a sexual assault...
A human papillomavirus (HPV), a member of the papillomavirus family, is capable of infecting humans. HPVs establish productive infections in the skin or mucous membranes. Most of the 200 known types cause no symptoms in most people. Some types can cause warts, while others can lead to cancer. There are more than 30 to 40 types of HPV that are typically transmitted through sexual contact and infect the anogenital region. High risk HPV, can lead to cancer, in fact HPV infection is a cause of...
